 BASKING RIDGE, NJ, May 11, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- Timber Pharmaceuticals, Inc. Timber or the Company NYSE American: TMBR, a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the first quarter ended March 31, 2021. 